BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15158001)

  • 1. Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits.
    Papiol S; Arias B; Barrantes-Vidal N; Guitart M; Salgado P; Catalán R; Fañanás L
    Neurosci Lett; 2004 Jun; 363(1):78-80. PubMed ID: 15158001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human p53 tumor suppressor gene (TP53) and schizophrenia: case-control and family studies.
    Ni X; Trakalo J; Valente J; Azevedo MH; Pato MT; Pato CN; Kennedy JL
    Neurosci Lett; 2005 Nov; 388(3):173-8. PubMed ID: 16039051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women.
    Sazci A; Ergul E; Kucukali I; Kara I; Kaya G
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1113-23. PubMed ID: 16084002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients.
    Molina V; Papiol S; Sanz J; Rosa A; Arias B; Fatjó-Vilas M; Calama J; Hernández AI; Bécker J; Fañanás L
    Neuroimage; 2011 May; 56(1):45-51. PubMed ID: 21296169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.
    Tan XL; Popanda O; Ambrosone CB; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Chang-Claude J
    Breast Cancer Res Treat; 2006 Jun; 97(3):255-62. PubMed ID: 16331344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
    Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
    Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
    Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic structure of the dopamine receptor D4 gene (DRD4) and lack of association with schizophrenia in Japanese patients.
    Mitsuyasu H; Kawasaki H; Ninomiya H; Kinukawa N; Yamanaka T; Tahira T; Stanton VP; Springett GM; Hayashi K; Tashiro N; Kanba S
    J Psychiatr Res; 2007 Nov; 41(9):763-75. PubMed ID: 16887146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Alvarez V; Coto E; Fernández JM; Bascarán MT; Bousoño M; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):741-5. PubMed ID: 17291660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TP53 16-bp duplication polymorphism is enriched in endometriosis patients.
    Gallegos-Arreola MP; Valencia-Rodríguez LE; Puebla-Pérez AM; Figuera LE; Zúñiga-González GM
    Gynecol Obstet Invest; 2012; 73(2):118-23. PubMed ID: 22353881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
    Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
    Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX2 and p53 risk-alleles coexist in COPD.
    Arif E; Vibhuti A; Deepak D; Singh B; Siddiqui MS; Pasha MA
    Clin Chim Acta; 2008 Nov; 397(1-2):48-50. PubMed ID: 18692035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
    Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.